ID   VEGFA_RAT               Reviewed;         214 AA.
AC   P16612; Q541S6; Q91ZE1; Q9JKX7; Q9QXG6; Q9QXG7;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2001, sequence version 2.
DT   02-OCT-2024, entry version 193.
DE   RecName: Full=Vascular endothelial growth factor A;
DE            Short=VEGF-A;
DE   AltName: Full=Vascular permeability factor;
DE            Short=VPF;
DE   Flags: Precursor;
GN   Name=Vegfa; Synonyms=Vegf;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM VEGF-A164), AND PROTEIN SEQUENCE OF
RP   27-190.
RX   PubMed=2320579; DOI=10.1073/pnas.87.7.2628;
RA   Conn G., Bayne M.L., Soderman D.D., Kwok P.W., Sullivan K.A., Palisi T.M.,
RA   Hope D.A., Thomas K.A.;
RT   "Amino acid and cDNA sequences of a vascular endothelial cell mitogen that
RT   is homologous to platelet-derived growth factor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:2628-2633(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS VEGF-A188; VEGF-A164; VEGF-A144 AND
RP   VEGF-A120).
RX   PubMed=11163598; DOI=10.1016/s0003-9969(00)00081-9;
RA   Ishii H., Oota I., Takuma T., Inomata K.;
RT   "Developmental expression of vascular endothelial growth factor in the
RT   masseter muscle of rats.";
RL   Arch. Oral Biol. 46:77-82(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS VEGF-A164 AND VEGF-A188).
RC   STRAIN=Sprague-Dawley;
RA   Marion S., Lee T.-C.;
RT   "Cloning of multiple VEGF splice variants from hypoxic neonatal rat
RT   cardiomyocytes.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PROTEIN SEQUENCE OF 27-40, AND SUBUNIT.
RC   TISSUE=Glial tumor;
RX   PubMed=7706320; DOI=10.1074/jbc.270.13.7717;
RA   DiSalvo J., Bayne M.L., Conn G., Kwok P.W., Trivedi P.G., Soderman D.D.,
RA   Palisi T.M., Sullivan K.A., Thomas K.A.;
RT   "Purification and characterization of a naturally occurring vascular
RT   endothelial growth factor.placenta growth factor heterodimer.";
RL   J. Biol. Chem. 270:7717-7723(1995).
RN   [5]
RP   FUNCTION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=10878616;
RX   DOI=10.1002/1097-0177(200007)218:3<507::aid-dvdy1012>3.0.co;2-5;
RA   Pepper M.S., Baetens D., Mandriota S.J., Di Sanza C., Oikemus S.,
RA   Lane T.F., Soriano J.V., Montesano R., Iruela-Arispe M.L.;
RT   "Regulation of VEGF and VEGF receptor expression in the rodent mammary
RT   gland during pregnancy, lactation, and involution.";
RL   Dev. Dyn. 218:507-524(2000).
CC   -!- FUNCTION: Growth factor active in angiogenesis, vasculogenesis and
CC       endothelial cell growth. Induces endothelial cell proliferation,
CC       promotes cell migration, inhibits apoptosis and induces
CC       permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and
CC       KDR/VEGFR2 receptors, heparan sulfate and heparin. May play a role in
CC       increasing vascular permeability during lactation, when increased
CC       transport of molecules from the blood is required for efficient milk
CC       protein synthesis. Binding to NRP1 receptor initiates a signaling
CC       pathway needed for motor neuron axon guidance and cell body migration,
CC       including for the caudal migration of facial motor neurons from
CC       rhombomere 4 to rhombomere 6 during embryonic development (By
CC       similarity). Also binds the DEAR/FBXW7-AS1 receptor (By similarity).
CC       {ECO:0000250|UniProtKB:P15692, ECO:0000250|UniProtKB:Q00731,
CC       ECO:0000269|PubMed:10878616}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:7706320). Also found as
CC       heterodimer with PGF (PubMed:7706320). Interacts with NRP1 (By
CC       similarity). Interacts with isoform 2 of BSG (By similarity). Interacts
CC       with CD82; this interaction inhibits VEGFA-mediated signaling pathway
CC       (By similarity). {ECO:0000250|UniProtKB:P15692,
CC       ECO:0000269|PubMed:7706320}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Note=VEGF-A120 is acidic
CC       and freely secreted. VEGF-A164 is more basic, has heparin-binding
CC       properties and, although a significant proportion remains cell-
CC       associated, most is freely secreted. VEGF-A188 is very basic, it is
CC       cell-associated after secretion and is bound avidly by heparin and the
CC       extracellular matrix, although it may be released as a soluble form by
CC       heparin, heparinase or plasmin (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=VEGF-A188;
CC         IsoId=P16612-1; Sequence=Displayed;
CC       Name=VEGF-A164;
CC         IsoId=P16612-2; Sequence=VSP_004629, VSP_004630;
CC       Name=VEGF-A144;
CC         IsoId=P16612-3; Sequence=VSP_004632;
CC       Name=VEGF-A120;
CC         IsoId=P16612-4; Sequence=VSP_004631;
CC   -!- TISSUE SPECIFICITY: Expressed in the pituitary, in brain, in
CC       particularly in supraoptic and paraventricular nuclei and the choroid
CC       plexus. Also found abundantly in the corpus luteum of the ovary and in
CC       kidney glomeruli. Expressed in the ductal epithelial cells of post-
CC       pubertal mammary glands. Expressed in the ductal and alveolar
CC       epithelial cells throughout the whole period of gestational evolution,
CC       lactation and involution. {ECO:0000269|PubMed:10878616}.
CC   -!- DEVELOPMENTAL STAGE: Increases during pregnancy (5.0-fold increase on
CC       day 12 with a subsequent decrease on day 18) and during lactation
CC       (18.5-fold increase on day 7). Levels appear to be minimally altered
CC       during involution. {ECO:0000269|PubMed:10878616}.
CC   -!- SIMILARITY: Belongs to the PDGF/VEGF growth factor family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M32167; AAA41211.1; -; mRNA.
DR   EMBL; AF215725; AAF19211.1; -; mRNA.
DR   EMBL; AF215726; AAF19212.1; -; mRNA.
DR   EMBL; AF222779; AAF25958.1; -; mRNA.
DR   EMBL; AY033506; AAL07526.1; -; mRNA.
DR   EMBL; AY033508; AAL07528.1; -; mRNA.
DR   PIR; A35987; A35987.
DR   RefSeq; NP_001103804.1; NM_001110334.2.
DR   RefSeq; NP_001274036.1; NM_001287107.1. [P16612-1]
DR   RefSeq; NP_001274037.1; NM_001287108.1. [P16612-2]
DR   RefSeq; NP_001274039.1; NM_001287110.1. [P16612-4]
DR   RefSeq; NP_001274040.1; NM_001287111.1.
DR   RefSeq; NP_001274041.1; NM_001287112.1. [P16612-3]
DR   RefSeq; NP_001274043.1; NM_001287114.1.
DR   RefSeq; NP_114024.2; NM_031836.3.
DR   AlphaFoldDB; P16612; -.
DR   SMR; P16612; -.
DR   BioGRID; 249830; 2.
DR   STRING; 10116.ENSRNOP00000026637; -.
DR   GlyCosmos; P16612; 1 site, No reported glycans.
DR   GlyGen; P16612; 1 site.
DR   PhosphoSitePlus; P16612; -.
DR   PaxDb; 10116-ENSRNOP00000026637; -.
DR   ABCD; P16612; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000044163.5; ENSRNOP00000050127.3; ENSRNOG00000019598.9. [P16612-4]
DR   GeneID; 83785; -.
DR   KEGG; rno:83785; -.
DR   UCSC; RGD:619991; rat. [P16612-1]
DR   AGR; RGD:619991; -.
DR   CTD; 7422; -.
DR   RGD; 619991; Vegfa.
DR   eggNOG; ENOG502QVI8; Eukaryota.
DR   GeneTree; ENSGT00940000157284; -.
DR   InParanoid; P16612; -.
DR   OrthoDB; 4231319at2759; -.
DR   PhylomeDB; P16612; -.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-194313; VEGF ligand-receptor interactions.
DR   Reactome; R-RNO-195399; VEGF binds to VEGFR leading to receptor dimerization.
DR   Reactome; R-RNO-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-RNO-5218921; VEGFR2 mediated cell proliferation.
DR   PRO; PR:P16612; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   GO; GO:0005912; C:adherens junction; ISO:RGD.
DR   GO; GO:0005604; C:basement membrane; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0016020; C:membrane; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0030141; C:secretory granule; ISO:RGD.
DR   GO; GO:1990150; C:VEGF-A complex; ISO:RGD.
DR   GO; GO:0031982; C:vesicle; IDA:RGD.
DR   GO; GO:0042056; F:chemoattractant activity; IMP:RGD.
DR   GO; GO:0005125; F:cytokine activity; ISO:RGD.
DR   GO; GO:0001968; F:fibronectin binding; ISO:RGD.
DR   GO; GO:0008083; F:growth factor activity; IDA:RGD.
DR   GO; GO:0019838; F:growth factor binding; IPI:RGD.
DR   GO; GO:0008201; F:heparin binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0005161; F:platelet-derived growth factor receptor binding; ISO:RGD.
DR   GO; GO:0048018; F:receptor ligand activity; ISO:RGD.
DR   GO; GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; ISO:RGD.
DR   GO; GO:0043183; F:vascular endothelial growth factor receptor 1 binding; ISO:RGD.
DR   GO; GO:0043184; F:vascular endothelial growth factor receptor 2 binding; IMP:RGD.
DR   GO; GO:0005172; F:vascular endothelial growth factor receptor binding; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; IMP:RGD.
DR   GO; GO:0060978; P:angiogenesis involved in coronary vascular morphogenesis; IMP:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0048844; P:artery morphogenesis; ISO:RGD.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0048514; P:blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0001974; P:blood vessel remodeling; IMP:RGD.
DR   GO; GO:0060346; P:bone trabecula formation; ISO:RGD.
DR   GO; GO:0061430; P:bone trabecula morphogenesis; ISO:RGD.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; ISO:RGD.
DR   GO; GO:0055013; P:cardiac muscle cell development; ISO:RGD.
DR   GO; GO:0060948; P:cardiac vascular smooth muscle cell development; ISO:RGD.
DR   GO; GO:0060326; P:cell chemotaxis; IMP:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0002042; P:cell migration involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; ISO:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0071391; P:cellular response to estrogen stimulus; IEP:RGD.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; ISO:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISO:RGD.
DR   GO; GO:1904568; P:cellular response to wortmannin; IEP:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0097533; P:cellular stress response to acid chemical; ISO:RGD.
DR   GO; GO:0071679; P:commissural neuron axon guidance; ISO:RGD.
DR   GO; GO:0060982; P:coronary artery morphogenesis; ISO:RGD.
DR   GO; GO:0003169; P:coronary vein morphogenesis; ISO:RGD.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; ISO:RGD.
DR   GO; GO:0035767; P:endothelial cell chemotaxis; ISO:RGD.
DR   GO; GO:0043542; P:endothelial cell migration; ISO:RGD.
DR   GO; GO:0001935; P:endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0030855; P:epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0002070; P:epithelial cell maturation; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0042462; P:eye photoreceptor cell development; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0003007; P:heart morphogenesis; ISO:RGD.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0050930; P:induction of positive chemotaxis; IBA:GO_Central.
DR   GO; GO:0001822; P:kidney development; ISO:RGD.
DR   GO; GO:0007595; P:lactation; ISO:RGD.
DR   GO; GO:0048286; P:lung alveolus development; IMP:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0060426; P:lung vasculature development; ISO:RGD.
DR   GO; GO:0036303; P:lymph vessel morphogenesis; ISO:RGD.
DR   GO; GO:0001946; P:lymphangiogenesis; ISO:RGD.
DR   GO; GO:0030225; P:macrophage differentiation; ISO:RGD.
DR   GO; GO:0060749; P:mammary gland alveolus development; ISO:RGD.
DR   GO; GO:0007498; P:mesoderm development; ISO:RGD.
DR   GO; GO:0030224; P:monocyte differentiation; ISO:RGD.
DR   GO; GO:0097475; P:motor neuron migration; ISS:UniProtKB.
DR   GO; GO:0048255; P:mRNA stabilization; IDA:RGD.
DR   GO; GO:1903392; P:negative regulation of adherens junction organization; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:1905604; P:negative regulation of blood-brain barrier permeability; ISO:RGD.
DR   GO; GO:0045779; P:negative regulation of bone resorption; IMP:RGD.
DR   GO; GO:0022408; P:negative regulation of cell-cell adhesion; ISO:RGD.
DR   GO; GO:2000048; P:negative regulation of cell-cell adhesion mediated by cadherin; ISO:RGD.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:1903141; P:negative regulation of establishment of endothelial barrier; ISO:RGD.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0043069; P:negative regulation of programmed cell death; IMP:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IDA:RGD.
DR   GO; GO:0007405; P:neuroblast proliferation; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; IMP:RGD.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:RGD.
DR   GO; GO:0001541; P:ovarian follicle development; ISO:RGD.
DR   GO; GO:0050918; P:positive chemotaxis; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IDA:RGD.
DR   GO; GO:0048842; P:positive regulation of axon extension involved in axon guidance; ISO:RGD.
DR   GO; GO:0043536; P:positive regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:1903589; P:positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0090190; P:positive regulation of branching involved in ureteric bud morphogenesis; ISO:RGD.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; ISO:RGD.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0038091; P:positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:2001028; P:positive regulation of endothelial cell chemotaxis; ISO:RGD.
DR   GO; GO:0038033; P:positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0010595; P:positive regulation of endothelial cell migration; ISS:UniProtKB.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; ISS:UniProtKB.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:1901492; P:positive regulation of lymphangiogenesis; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0060754; P:positive regulation of mast cell chemotaxis; IBA:GO_Central.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; ISO:RGD.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; ISO:RGD.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; ISO:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0050927; P:positive regulation of positive chemotaxis; ISO:RGD.
DR   GO; GO:0090037; P:positive regulation of protein kinase C signaling; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0031334; P:positive regulation of protein-containing complex assembly; ISS:UniProtKB.
DR   GO; GO:0002092; P:positive regulation of receptor internalization; ISO:RGD.
DR   GO; GO:0009967; P:positive regulation of signal transduction; IDA:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:1903672; P:positive regulation of sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:1901165; P:positive regulation of trophoblast cell migration; ISO:RGD.
DR   GO; GO:1900748; P:positive regulation of vascular endothelial growth factor signaling pathway; ISO:RGD.
DR   GO; GO:0043117; P:positive regulation of vascular permeability; IMP:RGD.
DR   GO; GO:0031077; P:post-embryonic camera-type eye development; ISO:RGD.
DR   GO; GO:0060319; P:primitive erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:0045601; P:regulation of endothelial cell differentiation; ISO:RGD.
DR   GO; GO:0040008; P:regulation of growth; ISO:RGD.
DR   GO; GO:1901532; P:regulation of hematopoietic progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0010749; P:regulation of nitric oxide mediated signal transduction; ISO:RGD.
DR   GO; GO:0071548; P:response to dexamethasone; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0051593; P:response to folic acid; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IDA:RGD.
DR   GO; GO:0070482; P:response to oxygen levels; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0033189; P:response to vitamin A; IEP:RGD.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; ISO:RGD.
DR   GO; GO:0002040; P:sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0043129; P:surfactant homeostasis; ISO:RGD.
DR   GO; GO:0042088; P:T-helper 1 type immune response; IDA:RGD.
DR   GO; GO:0048771; P:tissue remodeling; IEP:RGD.
DR   GO; GO:0035148; P:tube formation; ISS:UniProtKB.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; IMP:RGD.
DR   GO; GO:0036324; P:vascular endothelial growth factor receptor-2 signaling pathway; ISO:RGD.
DR   GO; GO:0038084; P:vascular endothelial growth factor signaling pathway; ISO:RGD.
DR   GO; GO:0061042; P:vascular wound healing; ISO:RGD.
DR   GO; GO:0001944; P:vasculature development; ISO:RGD.
DR   GO; GO:0042311; P:vasodilation; ISO:RGD.
DR   CDD; cd00135; PDGF; 1.
DR   Gene3D; 2.10.90.10; Cystine-knot cytokines; 1.
DR   Gene3D; 2.10.160.10; Vascular endothelial growth factor, heparin-binding domain; 1.
DR   InterPro; IPR029034; Cystine-knot_cytokine.
DR   InterPro; IPR023581; PD_growth_factor_CS.
DR   InterPro; IPR000072; PDGF/VEGF_dom.
DR   InterPro; IPR050507; PDGF/VEGF_growth_factor.
DR   InterPro; IPR027928; VEGF_C.
DR   InterPro; IPR036841; VEGF_C_sf.
DR   PANTHER; PTHR12025; VASCULAR ENDOTHELIAL GROWTH FACTOR; 1.
DR   PANTHER; PTHR12025:SF5; VASCULAR ENDOTHELIAL GROWTH FACTOR A; 1.
DR   Pfam; PF00341; PDGF; 1.
DR   Pfam; PF14554; VEGF_C; 1.
DR   SMART; SM00141; PDGF; 1.
DR   SUPFAM; SSF57501; Cystine-knot cytokines; 1.
DR   SUPFAM; SSF57593; Heparin-binding domain from vascular endothelial growth factor; 1.
DR   PROSITE; PS00249; PDGF_1; 1.
DR   PROSITE; PS50278; PDGF_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Angiogenesis; Developmental protein; Differentiation;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Growth factor;
KW   Heparin-binding; Mitogen; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000269|PubMed:2320579,
FT                   ECO:0000269|PubMed:7706320"
FT   CHAIN           27..214
FT                   /note="Vascular endothelial growth factor A"
FT                   /id="PRO_0000023390"
FT   REGION          131..159
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        144..159
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        100
FT                   /note="N-linked (GlcNAc...) asparagine"
FT   DISULFID        51..93
FT                   /evidence="ECO:0000250"
FT   DISULFID        76
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250"
FT   DISULFID        82..127
FT                   /evidence="ECO:0000250"
FT   DISULFID        85
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250"
FT   DISULFID        86..129
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         140
FT                   /note="K -> N (in isoform VEGF-A164)"
FT                   /evidence="ECO:0000303|PubMed:11163598,
FT                   ECO:0000303|PubMed:2320579, ECO:0000303|Ref.3"
FT                   /id="VSP_004629"
FT   VAR_SEQ         141..208
FT                   /note="Missing (in isoform VEGF-A120)"
FT                   /evidence="ECO:0000303|PubMed:11163598"
FT                   /id="VSP_004631"
FT   VAR_SEQ         141..164
FT                   /note="Missing (in isoform VEGF-A164)"
FT                   /evidence="ECO:0000303|PubMed:11163598,
FT                   ECO:0000303|PubMed:2320579, ECO:0000303|Ref.3"
FT                   /id="VSP_004630"
FT   VAR_SEQ         165..208
FT                   /note="Missing (in isoform VEGF-A144)"
FT                   /evidence="ECO:0000303|PubMed:11163598"
FT                   /id="VSP_004632"
FT   CONFLICT        101
FT                   /note="V -> A (in Ref. 2; AAF19212)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   214 AA;  25239 MW;  60FBB876F5304946 CRC64;
     MNFLLSWVHW TLALLLYLHH AKWSQAAPTT EGEQKAHEVV KFMDVYQRSY CRPIETLVDI
     FQEYPDEIEY IFKPSCVPLM RCAGCCNDEA LECVPTSESN VTMQIMRIKP HQSQHIGEMS
     FLQHSRCECR PKKDRTKPEK KSVRGKGKGQ KRKRKKSRFK SWSVHCEPCS ERRKHLFVQD
     PQTCKCSCKN TDSRCKARQL ELNERTCRCD KPRR
//
